These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. [The humoral immunologic picture in repeatedly dialyzed patients as compared with those with residual diuresis]. Ursea N; Cristian R; Penescu M; Patrichi D; Călăraşu P; Luban F Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1983; 35(6):541-4. PubMed ID: 6143376 [No Abstract] [Full Text] [Related]
14. [Sepsis in patients with terminal chronic kidney failure (a review of the literature)]. Filiptsev PIa; Vetchinnikova ON; Cherniakov VL Khirurgiia (Mosk); 1988 Mar; (3):131-7. PubMed ID: 3290567 [No Abstract] [Full Text] [Related]
15. [Further studies on the cellular defense mechanism in patients with terminal kidney failure and on treatment using intermittent hemodialysis]. Reis HE; Cremer W; Heimsoth VH; Wetter O; Eitelhuber U Verh Dtsch Ges Inn Med; 1974; 80():749-52. PubMed ID: 4548993 [No Abstract] [Full Text] [Related]
16. Plasmapheresis holds distinct advantages for 21st century uremia therapy. Nose Y; Smith JW; Malchesky PS Kidney Int Suppl; 1985 Dec; 17():S131-2. PubMed ID: 3867783 [No Abstract] [Full Text] [Related]
17. Proliferation in autologous mixed lymphocyte reactions, expression of HLA-class II antigen and serum immunomodulatory activity in patients with renal insufficiency on chronic dialysis. Puppo F; Gurreri G; Pattarini R; Ranise A; Indiveri F Allergol Immunopathol (Madr); 1991; 19(4):167-73. PubMed ID: 1840170 [TBL] [Abstract][Full Text] [Related]